MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a other report with the FDA on 2020-03-26 for 466FXXXX manufactured by Cordis Corporation.
[188515819]
As reported, a patient underwent placement of an optease inferior vena cava (ivc) filter. The indication for filter placement is not available. The filter subsequently malfunctioned and caused injury and damage to the patient, including, but not limited to, fracture and occlusion. The filter remains implanted; thus, unavailable for analysis. The product was not returned for analysis and the sterile lot number has not been provided; therefore, no device analysis nor device history record review could be performed. The optease vena cava filter is indicated for use in the prevention of recurrent pulmonary embolism (pe) via percutaneous placement in the vena cava for patients in which anticoagulants are contraindicated, anticoagulant therapy for thromboembolic disease has failed, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced or for chronic, recurrent pulmonary embolism where anticoagulant therapy has failed, or is contraindicated. The purpose of a vena cava filter is to catch thrombus from the lower extremities as it travels along normal blood flow patterns up towards the heart. The instructions for use (ifu) states filter fracture is a potential complication of vena cava filters. Anatomic locations that create concentrated stress points from filter deformation (for example, deployment at apex of scoliosis, overlapping of either of the renal ostia, or placement adjacent to a vertebral osteophyte) may contribute to fracture of a particular filter strut. Blood clots and occlusive thrombosis within the filter and vasculature do not represent a device malfunction. Clinical factors that may have influenced the event include patient, pharmacological and lesion characteristics. Without procedural films or images for review the reported event(s) could not be confirmed. Given the limited information available for review at this time, there is nothing to suggest that the reported events are related to the design and manufacturing process of the device; therefore, no corrective action will be taken. Should additional information become available, the file will be updated accordingly.
Patient Sequence No: 1, Text Type: N, H10
[188515820]
As reported by the legal brief, a patient underwent placement of an optease vena cava filter. The filter subsequently malfunctioned and caused injury and damage to the patient, including, but not limited to, fracture and occlusion.
Patient Sequence No: 1, Text Type: D, B5
Report Number | 1016427-2020-03964 |
MDR Report Key | 9883234 |
Report Source | OTHER |
Date Received | 2020-03-26 |
Date of Report | 2020-03-26 |
Date of Event | 2020-03-04 |
Date Mfgr Received | 2020-03-05 |
Date Added to Maude | 2020-03-26 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Manufacturer Contact | MRS. KARLA CASTRO |
Manufacturer Street | 14201 NW 60TH AVE |
Manufacturer City | MIAMI LAKES FL 33014 |
Manufacturer Country | US |
Manufacturer Postal | 33014 |
Manufacturer Phone | 7863138372 |
Manufacturer G1 | CORDIS CORPORATION |
Manufacturer Street | 14201 NW 60TH AVE |
Manufacturer City | MIAMI LAKES FL 33014 |
Manufacturer Country | US |
Manufacturer Postal Code | 33014 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | 466FXXXX |
Generic Name | FILTER, INTRAVASCULAR, CARDIOVASCULAR |
Product Code | DTK |
Date Received | 2020-03-26 |
Model Number | 466FXXXX |
Catalog Number | 466FXXXX |
Lot Number | UNK |
Operator | HEALTH PROFESSIONAL |
Device Availability | N |
Device Eval'ed by Mfgr | N |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | CORDIS CORPORATION |
Manufacturer Address | 14201 NW 60TH AVENUE MIAMI LAKES FL 33014 US 33014 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Life Threatening | 2020-03-26 |